Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Diurnal Ltd.
DescriptionModified-release hydrocortisone tablet
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAdrenal insufficiency
Indication DetailsTreat adrenal insufficiency; Treat congenital adrenal hyperplasia; Treat cortisol deficiency
Regulatory Designation EU - Orphan Drug (Treat adrenal insufficiency);
EU - Orphan Drug (Treat congenital adrenal hyperplasia)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today